Related Experiment Video
Updated: Dec 14, 2025

07:13
Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
1.9K
Surface Immobilized Nucleic Acid-Transcription Factor Quantum Dots for Biosensing
Mingfu Chen1, Thuy T Nguyen1, Nitinun Varongchayakul1
1Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA.
Advanced Healthcare Materials
|July 22, 2020
Summary
Researchers developed a novel surface-bound biosensor using allosteric transcription factors for detecting analytes. This new system offers an alternative to traditional aptamer or antibody-based sensors, showing promise for real-world applications.
Area of Science:
- Biotechnology
- Nanotechnology
- Analytical Chemistry
Background:
- Immobilizing biosensors on surfaces is crucial for practical applications.
- Conventional biosensors often rely on aptamers or antibodies for analyte detection.
- Allosteric transcription factors offer a potential alternative for molecular recognition.
Purpose of the Study:
- To prepare, characterize, and evaluate a surface-bound transcription factor-nucleic acid complex for analyte detection.
- To demonstrate a novel biosensor design using allosteric transcription factors.
- To establish a framework for future affinity-based biosensor development.
Main Methods:
- Fabrication of a gold surface modified with thiolated DNA and a quantum dot-linked transcription factor (TetR).
- Utilizing Förster resonance energy transfer (FRET) signal loss upon analyte binding.
- Real-time quantitative measurements of analyte concentration.
Main Results:
- The biosensor demonstrated a dose-dependent response to anhydrotetracycline (aTc) from 0-200 µm.
- A limit of detection of 80 nm for aTc was achieved.
- Analyte binding caused the release of TetR-quantum dots from the DNA, leading to signal loss.
Conclusions:
- A novel surface-bound biosensor utilizing allosteric transcription factors was successfully developed and characterized.
- This system provides a viable alternative to conventional biosensor components like aptamers and antibodies.
- The study lays the groundwork for designing future affinity-based biosensors with allosteric transcription factors for molecular recognition.

